CellRep
2 known investors
CellRep uses AI to discover small molecules that rejuvenate immune cells without genetic modification, with a lead application enhancing CAR-T therapy against solid tumors. The compounds are applied ex vivo during manufacturing as reagents, building a platform for cellular rejuvenation spanning cancer immunotherapy and longevity.